Detailed contribution information

Back to list

Contribution title Bimekizumab efficacy across subgroups of patients with moderate to severe plaque psoriasis: Pooled analysis from up to 3 years of treatment in 5 phase 3/3b clinical trials
Authors
  1. Bruce Strober Yale University School of Medicine
  2. James G. Krueger The Rockerfeller University
  3. Nina Magnolo University Hospital Münster
  4. Ronald Vender Dermatrials Research Inc.
  5. Wolf-Henning Boehncke Service de Dermatologie Hôpital Universitaire de Genève
  6. Chih-ho Hong University of British Columbia, Vancouver, British Columbia,
  7. Nicola Tilt UCB Pharma
  8. Fabienne Staelens UCB Pharma
  9. Bengt Hoepken UCB Pharma
  10. Susanne Wiegratz UCB Pharma
  11. Nicolas Hurni UCB-Pharma SA Presenter
  12. Carle Paul Department of Dermatology, Medical University of Toulouse
Form of presentation Poster
Topic
  • 1.1 Inflammatory and immune-mediated dermatoses